TARS
Tarsus Pharmaceuticals, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Tarsus Pharmaceuticals (TARS) Stock: Buy, Sell, or Hold?
$76.89
+0.13 (+0.17%)
▲
5d:
+13.88%
30d:
+6.36%
90d:
+11.11%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 03, 2026
0d
Protect TARS Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (57%)
Quality Score
54/100
Position
EXTENDED
30-Day Fair Range
$69.51 – $74.41
Position: EXTENDED
Forward P/E & Valuation
357.6x
STRETCHED
vs 39.3x historical avg
Wall Street Target
$103.44
+34.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$65.34 / $77.88
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: TARS trades at premium valuation expecting 108.7% growth. Hold existing positions but don't chase. Wait for better entry.
Get Alerted When TARS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.53
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TARS is currently trading at $76.89, which is considered extended relative to its 30-day fair value range of $69.51 to $74.41. From a valuation perspective, the stock is trading at a premium (Forward PE: 357.6) compared to its historical average (39.3). At these levels, the market is pricing in 108.7% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TARS is in a uptrend. The price is approaching resistance at $77.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $103.44 (+34.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TARS is in a uptrend. The price is approaching resistance at $77.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $103.44 (+34.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$69.51 -
$74.41
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.5%
Trading Range & Key Levels
30-Day Trading Range
$69.51 -
$74.41
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$5.29
(6.9%)
Support Level
$65.34
Resistance Level
$77.88
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding TARS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (59/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.5% below Wall St target ($103.44)
- BEARISH: Market expects 108.7% growth - appears too optimistic based on history
- NEUTRAL: Bottoming setup forming (59/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
357.63
Wall Street Target
$103.44
(+34.5%)
Revenue Growth (YoY)
63.9%
Profit Margin
-102.9%
Valuation Premium vs History
+108.7% premium
PE vs Historical
357.6 vs 39.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+108.7%
(market-implied from PE analysis)
1-Year Target
$115.34
(+50%)
2-Year Target
$173.00
(+125%)
3-Year Target
$259.50
(+238%)
3-Yr Target (if PE normalizes)
(PE: 358→39)
PE COMPRESSION
$28.52
(-63%)
Significant PE compression expected
Share TARS Analysis
Share this live TARS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TARS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
Trader on StockTwits expresses optimism towards $TARS stock performance despite market-wide red trends
Key Retail Themes:
Bullish sentiment towards $TARS
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TARS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 51 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 39 SELL |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 36 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
Advanced TARS Option Strategies
Professional options setups generated by AI based on today's TARS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TARS Research Pages
